Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;54(4):616-619.
doi: 10.1038/s41409-018-0346-7. Epub 2018 Oct 4.

Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study

Fuyao Chen  1   2 , Laura E Dellalana  1 , Jocelyn S Gandelman  3 , Arved Vain  1   4 , Madan H Jagasia  3 , Eric R Tkaczyk  5   6   7
Affiliations

Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study

Fuyao Chen et al. Bone Marrow Transplant. 2019 Apr.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosures: None

Figures

Figure 1.
Figure 1.
Myoton, a noninvasive handheld device, modified to isolate cutaneous tissue.
Figure 2.
Figure 2.
A) Box-and-whisker plot of skin stiffness of 8 cGVHD patients and 10 healthy controls, measured with the Myoton device in 9 anatomic regions. *Statistically significant differences (p<.05). ^Only 7 cGVHD patients were measured on the chest and 6 were measured on upper and lower back for patient comfort considerations. B) Box-and-whisker plot of skin stiffness measured with Myoton in 9 anatomic regions on 10 healthy controls, divided by BMI above 25 and BMI below 25.
See this image and copyright information in PMC

References

    1. Rodgers CJ, Burge S, Scarisbrick J, Peniket A. More than skin deep? Emerging therapies for chronic cutaneous GVHD. Bone Marrow Transplantation. 2012June;48(3):323–37. - PubMed
    1. Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, et al. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood. 2013January;121(25):5098–103. - PMC - PubMed
    1. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation. 2015;21(3). - PMC - PubMed
    1. Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014September;124(3):374–84. - PMC - PubMed
    1. Mitchell SA, Jacobsohn D, Powers KET, Carpenter PA, Flowers ME, Cowen EW, et al. A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change. Biology of Blood and Marrow Transplantation. 2011;17(11):1619–29. - PMC - PubMed

Publication types